Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

APRAMEYA ENGINEERING LTD. vs BALAXI PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    APRAMEYA ENGINEERING LTD. BALAXI PHARMA APRAMEYA ENGINEERING LTD./
BALAXI PHARMA
 
P/E (TTM) x - 12.2 - View Chart
P/BV x 5.7 2.2 258.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 APRAMEYA ENGINEERING LTD.   BALAXI PHARMA
EQUITY SHARE DATA
    APRAMEYA ENGINEERING LTD.
Mar-24
BALAXI PHARMA
Mar-24
APRAMEYA ENGINEERING LTD./
BALAXI PHARMA
5-Yr Chart
Click to enlarge
High RsNA686 0.0%   
Low RsNA400 0.0%   
Sales per share (Unadj.) Rs46.5221.4 21.0%  
Earnings per share (Unadj.) Rs2.5-2.2 -112.8%  
Cash flow per share (Unadj.) Rs2.5-0.3 -960.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs16.7181.3 9.2%  
Shares outstanding (eoy) m14.0010.90 128.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x02.5 0.0%   
Avg P/E ratio x0-248.0 -0.0%  
P/CF ratio (eoy) x0-2,051.6 -0.0%  
Price / Book Value ratio x03.0 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m05,919 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m27280 9.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6522,413 27.0%  
Other income Rs m56 72.7%   
Total revenues Rs m6562,419 27.1%   
Gross profit Rs m6462 101.8%  
Depreciation Rs m121 5.1%   
Interest Rs m2128 76.4%   
Profit before tax Rs m4620 228.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1144 25.9%   
Profit after tax Rs m35-24 -144.8%  
Gross profit margin %9.82.6 376.8%  
Effective tax rate %24.8218.5 11.3%   
Net profit margin %5.3-1.0 -536.2%  
BALANCE SHEET DATA
Current assets Rs m7032,102 33.4%   
Current liabilities Rs m397542 73.2%   
Net working cap to sales %47.064.6 72.7%  
Current ratio x1.83.9 45.7%  
Inventory Days Days208 265.4%  
Debtors Days Days3,252843 386.0%  
Net fixed assets Rs m50482 10.3%   
Share capital Rs m140109 128.5%   
"Free" reserves Rs m941,867 5.0%   
Net worth Rs m2341,976 11.8%   
Long term debt Rs m1240-   
Total assets Rs m7522,583 29.1%  
Interest coverage x3.21.7 183.7%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.90.9 92.7%   
Return on assets %7.40.1 5,042.6%  
Return on equity %14.8-1.2 -1,224.5%  
Return on capital %18.82.4 776.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m0648 0.0%   
Fx outflow Rs m019 0.0%   
Net fx Rs m0629 0.0%   
CASH FLOW
From Operations Rs m-10049 -205.0%  
From Investments Rs m-10-10 95.4%  
From Financial Activity Rs m111303 36.7%  
Net Cashflow Rs m1341 0.4%  

Share Holding

Indian Promoters % 73.5 66.0 111.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.7 16.5 34.6%  
FIIs % 2.5 16.5 15.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.5 34.0 77.8%  
Shareholders   749 7,863 9.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare APRAMEYA ENGINEERING LTD. With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    MSTC    


More on APRAMEYA ENGINEERING LTD. vs BALAXI PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

APRAMEYA ENGINEERING LTD. vs BALAXI PHARMA Share Price Performance

Period APRAMEYA ENGINEERING LTD. BALAXI PHARMA
1-Day 3.78% 0.95%
1-Month -4.70% -17.04%
1-Year -7.41% -80.95%
3-Year CAGR -2.53% -49.75%
5-Year CAGR -1.53% -33.83%

* Compound Annual Growth Rate

Here are more details on the APRAMEYA ENGINEERING LTD. share price and the BALAXI PHARMA share price.

Moving on to shareholding structures...

The promoters of APRAMEYA ENGINEERING LTD. hold a 73.5% stake in the company. In case of BALAXI PHARMA the stake stands at 66.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of APRAMEYA ENGINEERING LTD. and the shareholding pattern of BALAXI PHARMA.

Finally, a word on dividends...

In the most recent financial year, APRAMEYA ENGINEERING LTD. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BALAXI PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of APRAMEYA ENGINEERING LTD., and the dividend history of BALAXI PHARMA.

For a sector overview, read our finance sector report.



Today's Market

Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers Sensex Today Ends 239 Points Higher | Nifty Above 23,500 | HDFC Bank & Tech Mahindra Top Gainers(Closing)

On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.